Clinical Drug Experience Knowledgebase

bevacizumab (avastin) (1 trial)

capecitabine (xeloda) (3 trials)

cetuximab (erbitux) (2 trials)

cisplatin (platinol) (1 trial)

dasatinib (sprycel) (1 trial)

docetaxel (taxotere) (1 trial)

doxorubicin (Doxil) (1 trial)

erlotinib (tarceva) (2 trials)

etoposide (vepesid) (1 trial)

fluorouracil (efudex) (3 trials)

gemcitabine (gemzar) (3 trials)

irinotecan (Camptosar) (5 trials)

mitomycin (mutamycin) (1 trial)

oxaliplatin (eloxatin) (3 trials)

paclitaxel (taxol) (2 trials)

pemetrexed (alimta) (1 trial)

Raltitrexed (1 trial)

sorafenib (nexavar) (1 trial)

topotecan (hycamtin) (1 trial)

vinorelbine (navelbine) (1 trial)

buparlisib (1 trial)

leucovorin (1 trial)